Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Glenmark-backed biotech firm unveils new cancer drug candidate for solid tumours
Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company focused on developing Multispecific antibodies in oncology, has announced a new development candidate, ISB 2301, for the potential treatment of multiple solid tumor indications.
HealthCare Global posts PAT of Rs 2.17 crore in Q4
HealthCare Global Enterprises has reported 70.5% drop in consolidated net profit to Rs 2.17 crore despite a 11.5% increase in revenue to Rs 650.29 crore in Q4 FY26 as compared with Q4 FY25.
Healthcare Global Enterprises consolidated net profit declines 70.52% in the March 2026 quarter
Sales rise 11.46% to Rs 650.29 crore
Bayer bets big on 'self-care' market to deepen India play
Global pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market estimated at ₹40,000 crore. The company is launching new products, including the antacid Alka-Seltzer, and aims to reach 100 million households within four years, positioning India as a top global market.
HCG opens new Bengaluru facility with Rs 129 crore investment
HealthCare Global Enterprises (HCG) has inaugurated a new 132-bed oncology facility in Bengaluru, marking its third hospital in the city with an investment of nearly Rs 129 crore. The advanced center utilizes cutting-edge MRI scanner machines for precise cancer treatment, aiming to manage even advanced metastatic cases. This expansion follows KKR's significant stake acquisition in HCG last year.
GCC boom pushes Hyderabad office rents to all-time high, at par with Bengaluru
Hyderabad's office rentals hit a record high in Q1 2026, nearing Bengaluru's rates due to robust demand from global capability centers and large occupiers. This surge, coupled with no new completions, tightened availability and drove up average rents to Rs 92.2 per sq ft, with Madhapur seeing even higher rates.
Fertilisers not easily available in international market, pushes for organic farming: Union Minister Shivraj Singh Chouhan
Union Agriculture Minister Shivraj Singh Chouhan highlighted global fertilizer procurement difficulties. He urged states and farmers to embrace organic farming for soil health. The government is committed to subsidies and plans new bills for quality pesticides and seeds. Farmers are advised to grow drought-resistant crops due to El Nino forecasts.
Nifty could hit 27,000 once geopolitical tensions ease: Bajaj Finserv AMC CIO
Bajaj Finserv AMC CIO Nimesh Chandan projects 15% earnings growth for Nifty in FY28, with EPS rising to the ₹1,420–1,440 range, making valuations look attractive. He backs metals, construction, and cement as long-term plays on a global supply chain shift, holds gold and silver in the multi-asset portfolio, and flags El Niño and elevated US yields as key risks keeping Indian interest rates high in the near term.
Q4 Results LIVE Updates: IOC, Astral, Afcons react to earnings; BPCL, BEL report today
Q4 Results LIVE Updates: BPCL, Zydus Life, BEL, BLS International, Dhanuka Agri, Dredging Corp, Eureka Forbes, Hatsun Agro, Healthcare Global, J Kumar Infra, PI Industries, PNC Infratech, Prince Pipes, Safari Industries, RITES, Trident, Zee Entertainment, Shaily Engineering are among the other important numbers to track today along with result reactions from IOC, IGL, Afcons, Astral and many others. Stay tuned for all the live result reactions right here.
Vinay Rajani of HDFC Sec suggests Oracle Financial Services, Sun Pharma shares to buy
Indian equity markets experienced a significant selloff on May 18, with Sensex and Nifty 50 dropping over 1%. The BSE Sensex fell over 1,000 points, erasing nearly ₹9 lakh crore in investor wealth amid weak global cues and a bearish trend across sectors.
Eight Pharma stocks that should be on your radar on Monday
Pharmaceutical companies reported a slew of updates over the weekend. Earnings reactions from KIMS, Global Health, Gland Pharma, Aarti Drugs, to a USFDA observation list for Emcure Pharma, these are the drugmakers that should be on your radar today.
Prime Minister Modi's visit to the Netherlands: Here is why it is important to India
PM Narendra Modi visits the Netherlands May 15 to 17, India and the Netherlands sign multiple MoUs on strategic partnership, minerals, energy, agriculture, health, customs and education